CD11b+Ly6G+ are markers used to define granulocytic MDSCs or neutrophils, and the latter population is able to inhibit tumor growth by suppressing IL-17 expression at the early stage of tumorigenesis (67). This evidence concerns the gene IL17A and neoplasm.